Filter AGITG trials by
A phase II trial of neoadjuvant PD-1 vaccine IMU-201 (PD1-Vaxx) in operable MSI high colon cancer (CRC). Read More
STOPNET - Comparison of patient outcomes with or without continuation of somatostatin injections after the commencement of Peptide Receptor Radionuclide Therapy (PRRT) Read More
BIOMARCER-2 - Biomarker informed optimal management of advanced RAS wild type colorectal cancer in right sided disease Read More